title: PTH(1-34) Treatment Increases Bisphosphonate Turnover in Fracture Repair in Rats.
abstract: Bisphosphonates (BP) are antiresorptive drugs with a high affinity for bone. Despite the therapeutic success in treating osteoporosis and metabolic bone diseases, chronic BP usage has been associated with reduced repair of microdamage and atypical femoral fracture (AFF). The latter has a poor prognosis, and although anabolic interventions such as teriparatide (PTH(1-34) ) have been suggested as treatment options, there is a limited evidence base in support of their efficacy. Because PTH(1-34) acts to increase bone turnover, we hypothesized that it may be able to increase BP in turnover in the skeleton, which, in turn, may improve bone healing. To test this, we employed a mixture of fluorescent Alexa647-labelled pamidronate (Pam) and radiolabeled (14) C-ZA (zoledronic acid). These traceable BPs were dosed to Wistar rats in models of normal growth and closed fracture repair. Rats were cotreated with saline or 25 μg/kg/d PTH(1-34) , and the effects on BP liberation and bone healing were examined by X-ray, micro-CT, autoradiography, and fluorescent confocal microscopy. Consistent with increased BP remobilization with PTH(1-34) , there was a significant decrease in fluorescence in both the long bones and in the fracture callus in treated animals compared with controls. This was further confirmed by autoradiography for (14) C-ZA. In this model of acute BP treatment, callus bone volume (BV) was significantly increased in fractured limbs, and although we noted significant decreases in callus-bound BP with PTH(1-34) , these were not sufficient to alter this BV. However, increased intracellular BP was noted in resorbing osteoclasts, confirming that, in principle, PTH(1-34) increases bone turnover as well as BP turnover.
authors.affiliation: Orthopaedic Research and Biotechnology Unit, The Children's Hospital at Westmead, Sydney, Australia.|Discipline of Paediatrics and Child Health, Faculty of Medicine, University of Sydney, Sydney, Australia.
authors.forename: Ciara M
authors.initials: CM
authors.lastname: Murphy
authors.affiliation: Orthopaedic Research and Biotechnology Unit, The Children's Hospital at Westmead, Sydney, Australia.|Discipline of Paediatrics and Child Health, Faculty of Medicine, University of Sydney, Sydney, Australia.
authors.forename: Aaron
authors.initials: A
authors.lastname: Schindeler
authors.affiliation: Orthopaedic Research and Biotechnology Unit, The Children's Hospital at Westmead, Sydney, Australia.|Discipline of Paediatrics and Child Health, Faculty of Medicine, University of Sydney, Sydney, Australia.
authors.forename: Laurence C
authors.initials: LC
authors.lastname: Cantrill
authors.affiliation: Orthopaedic Research and Biotechnology Unit, The Children's Hospital at Westmead, Sydney, Australia.
authors.forename: Kathy
authors.initials: K
authors.lastname: Mikulec
authors.affiliation: Orthopaedic Research and Biotechnology Unit, The Children's Hospital at Westmead, Sydney, Australia.
authors.forename: Lauren
authors.initials: L
authors.lastname: Peacock
authors.affiliation: Orthopaedic Research and Biotechnology Unit, The Children's Hospital at Westmead, Sydney, Australia.|Discipline of Paediatrics and Child Health, Faculty of Medicine, University of Sydney, Sydney, Australia.
authors.forename: David G
authors.initials: DG
authors.lastname: Little
mesh_terms: D000818:Animals; D002247:Carbon Isotopes / Q000493:pharmacokinetics / Q000494:pharmacology; D004164:Diphosphonates / Q000493:pharmacokinetics / Q000494:pharmacology; D005264:Femoral Fractures / Q000188:drug therapy / Q000378:metabolism; D017102:Fracture Healing / Q000187:drug effects*; D007093:Imidazoles / Q000493:pharmacokinetics / Q000494:pharmacology; D007553:Isotope Labeling; D008297:Male; D000077268:Pamidronate; D010281:Parathyroid Hormone / Q000493:pharmacokinetics / Q000494:pharmacology; D051381:Rats; D017208:Rats, Wistar; D000077211:Zoledronic Acid
chemical_list: D002247:Carbon Isotopes; D004164:Diphosphonates; D007093:Imidazoles; D010281:Parathyroid Hormone; D000077211:Zoledronic Acid; D000077268:Pamidronate
keywords: BISPHOSPHONATES; BONE TURNOVER; FRACTURE REPAIR; PTH(1-34)